Please login to the form below

Not currently logged in
Email:
Password:

President Trump

This page shows the latest President Trump news and features for those working in and with pharma, biotech and healthcare.

Biologic patent exclusivity scrapped in new US trade deal

Biologic patent exclusivity scrapped in new US trade deal

President Trump has made drug pricing a key target for his administration, and both his Republican party and the opposition Democrat party are focusing on high drug prices as a major ... Responding to the latest trade negotiations, industry organisation

Latest news

More from news
Approximately 7 fully matching, plus 61 partially matching documents found.

Latest Intelligence

  • The Golden Goose The Golden Goose

    When President Trump complains of global ‘freeloaders’ in the drug trade, he is not completely off the mark. ... When efforts by the Trump administration to repeal and replace Obamacare lost momentum, it shifted to reducing drug costs.

  • The fight for affordable insulin The fight for affordable insulin

    Where previous administrations were opposed to importation from Canada and elsewhere, the Trump White House says it is in favour of individuals resorting to these measures, but wants to legislate to ... Recent weeks have seen President Trump shift his

  • The Orkambi blame game The Orkambi blame game

    These included questions to Jeff Leiden about his salary, the company’s profits and taxes paid in the UK, and allegations from President Trump that European countries such as the UK

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Current global president, worldwide research and development and medical, Mikael Dolsten, will also become chief medical officer. ... This was because Read had agreed to reverse previously announced price increases after being telephoned by President

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    Its highly fragmented nature leaves it ripe for further M&A activity - led by emboldened and cash-rich US firms if President Trump, via a low ‘repatriation tax’, opens the door ... And then there is the problem of public opinion. “We have a

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics